Onward

Recent Finacing

Equity

Recent Raise

$32M

ONWARD develops implantable (ARC-IM) and external (ARC-EX) spinal cord stimulation systems providing targeted stimulation to restore movement and function in spinal cord injury patients; ARC-EX is in the Up-LIFT trial.